111 related articles for article (PubMed ID: 30633389)
21. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
23. Quality assurance of magnetic resonance spectroscopic imaging-derived metabolic data.
Hunjan S; Adalsteinsson E; Kim DH; Harsh GR; Boyer AL; Spielman D; Xing L
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1159-73. PubMed ID: 14575849
[TBL] [Abstract][Full Text] [Related]
24. In vivo MR spectroscopic imaging of the prostate, from application to interpretation.
Tayari N; Heerschap A; Scheenen TWJ; Kobus T
Anal Biochem; 2017 Jul; 529():158-170. PubMed ID: 28167072
[TBL] [Abstract][Full Text] [Related]
25. Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment.
Lotumolo A; Caivano R; Rabasco P; Iannelli G; Villonio A; D' Antuono F; Gioioso M; Zandolino A; Macarini L; Guglielmi G; Cammarota A
Eur J Radiol; 2015 Dec; 84(12):2597-604. PubMed ID: 26391231
[TBL] [Abstract][Full Text] [Related]
26. Direct and indirect assessment of cancer metabolism explored by MRI.
Kishimoto S; Oshima N; Krishna MC; Gillies RJ
NMR Biomed; 2019 Oct; 32(10):e3966. PubMed ID: 30169896
[TBL] [Abstract][Full Text] [Related]
27. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
[TBL] [Abstract][Full Text] [Related]
28. Validation of in vivo MRS measures of metabolite concentrations in the human brain.
Dhamala E; Abdelkefi I; Nguyen M; Hennessy TJ; Nadeau H; Near J
NMR Biomed; 2019 Mar; 32(3):e4058. PubMed ID: 30663818
[TBL] [Abstract][Full Text] [Related]
29. Mapping metabolic changes associated with early Radiation Induced Lung Injury post conformal radiotherapy using hyperpolarized ¹³C-pyruvate Magnetic Resonance Spectroscopic Imaging.
Thind K; Jensen MD; Hegarty E; Chen AP; Lim H; Martinez-Santiesteban F; Van Dyk J; Wong E; Scholl TJ; Santyr GE
Radiother Oncol; 2014 Feb; 110(2):317-22. PubMed ID: 24440041
[TBL] [Abstract][Full Text] [Related]
30. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
31. Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
Vafaeyan H; Ebrahimzadeh SA; Rahimian N; Alavijeh SK; Madadi A; Faeghi F; Harirchian MH; Rad HS
Australas Phys Eng Sci Med; 2015 Dec; 38(4):611-8. PubMed ID: 26526449
[TBL] [Abstract][Full Text] [Related]
32. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse.
Pucar D; Koutcher JA; Shah A; Dyke JP; Schwartz L; Thaler H; Kurhanewicz J; Scardino PT; Kelly WK; Hricak H; Zakian KL
Clin Prostate Cancer; 2004 Dec; 3(3):174-81. PubMed ID: 15636684
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance spectroscopy in posterior fossa tumours: the tumour spectroscopic signature may improve discrimination in adults among haemangioblastoma, ependymal tumours, medulloblastoma, and metastasis.
Mora P; Pons A; Cos M; Camins A; Muntané A; Aguilera C; Arús C; Majós C
Eur Radiol; 2019 Jun; 29(6):2792-2801. PubMed ID: 30569184
[TBL] [Abstract][Full Text] [Related]
35. Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.
Ciezka M; Acosta M; Herranz C; Canals JM; Pumarola M; Candiota AP; Arús C
J Neurooncol; 2016 Aug; 129(1):67-76. PubMed ID: 27324642
[TBL] [Abstract][Full Text] [Related]
36. In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma.
Guo J; Higashi K; Yokota H; Nagao Y; Ueda Y; Kodama Y; Oguchi M; Taki S; Tonami H; Yamamoto I
J Nucl Med; 2004 Aug; 45(8):1334-9. PubMed ID: 15299058
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging.
Wiebenga OT; Klauser AM; Nagtegaal GJ; Schoonheim MM; Barkhof F; Geurts JJ; Pouwels PJ
NMR Biomed; 2014 Mar; 27(3):304-11. PubMed ID: 24399803
[TBL] [Abstract][Full Text] [Related]
38. Global brain metabolic quantification with whole-head proton MRS at 3 T.
Kirov II; Wu WE; Soher BJ; Davitz MS; Huang JH; Babb JS; Lazar M; Fatterpekar G; Gonen O
NMR Biomed; 2017 Oct; 30(10):. PubMed ID: 28678429
[TBL] [Abstract][Full Text] [Related]
39. Integration of MRI and MRS approaches to monitor molecular imaging and metabolomic effects of trabectedin on a preclinical ovarian cancer model.
Canese R; Palombelli G; Chirico M; Sestili P; Bagnoli M; Canevari S; Mezzanzanica D; Podo F; Iorio E
NMR Biomed; 2019 Oct; 32(10):e4016. PubMed ID: 30375088
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
